Erythropoietin (Epo) autocrine stimulation has been implicated in erythroblastic leukemia. To examine whether this stimulation could occur intracellularly, we developed Epo autocrine models of stimulation in the human pluripotent UT-7 cell line. Retroviral expression of Epo totally abolished the growth factor requirement of UT-7 cells. Autonomous proliferation was not cell density-dependent and occurred at a unicellular level, showing a genuine autocrine mode of stimulation. Total blockage of Epo secretion induced by the endoplasmic reticulum-retention amino acids Lys-Asp-GluLeu (KDEL) signals in 11 lines prevented autonomous proliferation, whereas a leaky retention system, observed in 3 other lines, resulted in limited autocrine stimulation without true long-term autonomous proliferation. Production of Epo, in contrast to KDEL-modified Epo, induced reductions in Epo ORMAL CELL GROWTH is usually regulated through paracrine or endocrine stimulation, ie, a growth factor produced by one cell type influences the proliferation of another cell through its diffusion in the extracellular space or the blood stream.' Autocrine stimulation occurs when a cell produces a growth factor influencing its own proliferation. These mechanisms of self-stimulation have been described in normal physiology, during inflammatory and repair processes or early embryogenesis, as well as in malignancies and have been shown to lead to aberrant cell proliferation and tum~rigenicity.~,~ The relationship between autocrine stimulation and malignant transformation is not entirely clear. Several investigators have suggested that autocrine stimulation may occur inside the cell; such an abnormal environment for receptor activation may bypass normal regulatory processes or induce abnormal transduction signal pathways leading to malignant transformation. Indeed, it has been suggested that, in a number of experimental models involving granulocyte-macrophage colony-stimulating factor (GM-CSF)4, interleukin 3 (IL-3)', the v-sis oncogene,6 or the basic fibroblast growth factor (bFGF)7, autocrine intracellular stimulation is involved in the malignant transformation. Evidence in favor of an intracellular process is based on a stimulation (1) that is independent of the cell density, ( 2 ) that is not inhibited by the addition of growth factorneutralizing antibodies but is inhibited by growth factor antisense oligonucleotides, and (3) that persists even when growth factor secretion is retained in the endoplasmic reticulum (ER). Nevertheless, this subject remains controversial because, in several models involving, for example, the Kfgfhst or the v-sis oncogenes, intracellular growth factors are unable to induce cell proliferation andor Erythropoietin (Epo) is the primary physiologic regulator of erythropoiesis." In adult mammals, Epo is mainly produced by kidney cells in response to hypoxia. In some erythroid malignancies, Epo may be implicated in an autocrine process of transformation. Indeed, Epo is produced by some erythroid cell lines infected by the Friend-murine leukemia virus" and also by most primary human erythroleukemic cells showing spontaneous in vitro growth.I3 In a previous study, we introduced and expressed the Epo gene in normal binding, Epo receptor (EpoR) mRNA, and phosphorylation levels similar to those induced by the addition of exogenous Epo to the parental cell line. In addition, autonomous growth and survival were inhibited by the addition of Epo-neutralizing antibodies, affording evidence that autocrine stimulation through EpoR activation takes place on the cell surface. Finally, phenotypic analysis of the virus-infected clones indicated that Epo production did not change the differentiative capacities of UT-7 cells. All these data show that Epo autocrine stimulation is dependent on Epo secretion and takes place on the cell surface. From all analyzed parameters, the effects of Epo autocrine stimulation and those of exogenously added Epo appear to be identical.
ORMAL CELL GROWTH is usually regulated through paracrine or endocrine stimulation, ie, a growth factor produced by one cell type influences the proliferation of another cell through its diffusion in the extracellular space or the blood stream.' Autocrine stimulation occurs when a cell produces a growth factor influencing its own proliferation. These mechanisms of self-stimulation have been described in normal physiology, during inflammatory and repair processes or early embryogenesis, as well as in malignancies and have been shown to lead to aberrant cell proliferation and tum~rigenicity.~,~ The relationship between autocrine stimulation and malignant transformation is not entirely clear. Several investigators have suggested that autocrine stimulation may occur inside the cell; such an abnormal environment for receptor activation may bypass normal regulatory processes or induce abnormal transduction signal pathways leading to malignant transformation. Indeed, it has been suggested that, in a number of experimental models involving granulocyte-macrophage colony-stimulating factor (GM-CSF)4, interleukin 3 (IL-3)', the v-sis oncogene, 6 or the basic fibroblast growth factor (bFGF)7, autocrine intracellular stimulation is involved in the malignant transformation. Evidence in favor of an intracellular process is based on a stimulation (1) that is independent of the cell density, ( 2 ) that is not inhibited by the addition of growth factorneutralizing antibodies but is inhibited by growth factor antisense oligonucleotides, and (3) that persists even when growth factor secretion is retained in the endoplasmic reticulum (ER). Nevertheless, this subject remains controversial because, in several models involving, for example, the Kfgfhst or the v-sis oncogenes, intracellular growth factors are unable to induce cell proliferation andor Erythropoietin (Epo) is the primary physiologic regulator of erythropoiesis." In adult mammals, Epo is mainly produced by kidney cells in response to hypoxia. In some erythroid malignancies, Epo may be implicated in an autocrine process of transformation. Indeed, Epo is produced by some erythroid cell lines infected by the Friend-murine leukemia virus" and also by most primary human erythroleukemic cells showing spontaneous in vitro growth.I3 In a previous study, we introduced and expressed the Epo gene in normal murine hemopoietic cells, using a helper-free nonreplicative retrovirus, to investigate the role of an Epo autocrine stimulation in the leukemic process.14 This procedure resulted in a proliferative syndrome without neoplastic transformation. Others, using different hemopoietic growth factors such as GM-CSF, IL-3, or granulocyte-CSF (G-CSF), showed similar results, suggesting that an autocrine stimulation is not sufficient to induce a leukemic transf~rmation.""~ In the Friend model of erythroleukemia, an Epo molecular mimicry by the recombinant env gene product of the Friend spleen-forming virus, a transmembrane glycoprotein called gp55, is responsible for the early polyclonal erythroblastosis." This erythroproliferative syndrome is very similar to the one induced by an Epo autocrine s t i m~l a t i o n l~.~~ but rapidly evolves into a true erythroblastic leukemia with the emergence of clonal leukemogenic cells.20 A very similar leukemic process has been described using a virus carrying a mutated Epo receptor (EpoR) that is constitutively activated (CEPOR).~' Although the precise role of gp55 and cEpoR in the leukemic process remain unclear, both events appear to trigger additional genetic events promoting the leukemic transformation, such as inactivation of the p53 gene andor activation of members of the ets oncogene far nil^.'^,^^ These data raised the question of why EpoR activation through an Epo autocrine stimulation does not allow the same rapid transformation.
One hypothesis explaining these differences is related to the localization (intracellular or extracellular) of the stimulation. It has been shown that EpoWgp55 complexes and disulfide-linked mutant cEpoR dimers accumulate in the ER.'".24 It was proposed, albeit controversially, that these events were involved in the induction of the disease." Similarly, we have previously shown that, in one case of human erythroleukemia, autonomous cell growth was inhibited by Epo mRNA antisense oligonucleotides but not by Epo-neutralizing antibodies, suggesting the occurrence of an intracellular mode of stimulation.13 In fact, it is still unknown whether an Epo autocrine stimulation may truly occur intracellularly or whether it has the same consequences on cell differentiation and proliferation as an extracellular stimulation.
To investigate this phenomenon, we have developed models of extracellular and intracellular autocrine stimulation using the human Epo-dependent cell line, UT-7. 26 Our results show that retroviral expression of Epo leads to an autonomous growth of the cell line affecting EpoR expression and phosphorylation. This Epo autocrine stimulation is inhibited by the presence of Epo antiserum. In contrast, retroviral expression of Epo that is modified with the ER-retention system amino acids Lys-Asp-Glu-Leu (KDEL) does not modify the proliferative or differentiative capacities of the cells and did not affect the EpoR metabolism. These data strongly suggest that Epo autocrine stimulation requires the interaction of Epo with its receptor on the cell surface.
MATERIALS AND METHODS
Cell cultures. Parental and virus-infected UT-7 cells" were cultured in Iscove's modified Dulbecco's medium (IMDM; GIBCO/ BRL, Grand Island, NY) or in methylcellulose semisolid medium, as previously described." Media contained 10% fetal calf serum (FCS) (Eurobio, Paris, France), recombinant human (rh) GM-CSF (2.5 ng/mL; Genetics Institute, Cambridge, MA), or rhEpo (2 U/ m L ; Amersham, Les Ulis, France). Cultures were performed at 37°C in a fully humidified atmosphere of 5% COz. The DaE7 cell line (Epo-dependent clone from the Da-l cell line,28.'9 obtained from Dr H. Nomura, Chugai Pharmaceutical CO, Shizucka, Japan) was cultured in IMDM containing 10% FCS in the presence of 2 U/mL of Epo. The FDC-P1 cell line (obtained from D. Metcalf, The Walter and Eliza Hall Institute, Melbourne, Australia) was cultured in Dulbecco's modified Eagle's medium (GIBCOBRL) containing 10%
FCS in the presence of 5% to 10% pokeweed mitogen-stimulated spleen cell-conditioned medium. The psi-2 cell line was cultured in Dulbecco's modified Eagle's medium containing 10% FCS (J. Bio, Les Ullis, France) in a fully humidified atmosphere of 10% COz.
The psi-CRIP cell line (obtained from 0. Danos, Institut Pasteur, Paris, France) was cultured in IMDM containing 10% new-born calf serum.
For cultures involving limiting cell dilution, UT-7 cells were seeded at 0.5 cell in 20 pL per well in five 60-microwell plates in the presence or absence of GM-CSF. After a l-hour sedimentation, the number of plated cells per well was recorded. Colony formation was observed after 8 days of incubation at 37°C.
Microwell assays3" were performed in duplicate by adding 200 cells (from the DaE7 or the UT-7 cell lines) in 10 p L volume of IMDM plus 10% FCS to serial twofold dilutions of (l) cell-conditioned media or cell lysates (Epo assays), (2) Epo standards (for Epo responsiveness studies), or (3) Epo neutralizing antibodies (for cell growth inhibition studies). Viable DaE7 or UT-7 cells were counted after 2 or 4 days of incubation at 3 7 T , respectively. For antibody experiments, control cultures were perfomed in the presence of GM-CSF or an excess of Epo (30 UlmL). The titer of the anti-Epo antibodies " was determined by adding Epo-stimulated cells ( I U/ mL) to serial twofold dilutions of the antibodies. The anti-Epo IgG fraction from the rabbit Epo antiserum was purified using diethylaminoethyl-Affi-Blue gel (Bio-Rad, Richmond, CA) chromatography.
Retrovirul vector construction and production (Fig l ) . All viruses are based on the MPZen2 vector containing a 3' myeloproliferative sarcoma virus long terminal repeat (LTR)."
To construct the ZenNeo vector, a HindIII-EcoRI fragment encoding the neomycine resistance (Neo) gene was inserted into the polylinker site of the MPZen2 plasmid DNA. To construct the ZenEpo retrovirus, a neomycine resistance gene controlled by the Simian virus 40 (SV40) early promoter-enhancer (SV), was inserted into the Clu I site of the previously described MPZenEpo virus.14 To construct the ZenEpoK virus, the BarnHI-BarnHI fragment of the cynomolgus monkey Epo cDNA sequence was removed from the MPZenEpo virus and subcloned into the M13 mp8 vector. Oligonucleotide-directed mutagenesis (Amersham) was performed using an oligonucleotide encoding a 12-amino acid sequence introducing the KDEL sequence in 5' of the Epo cDNA stop codon. This modification was confirmed by DNA sequencing. The modified Epo cDNA (EpoK) was inserted 5' of an SV40 early promoter-enhancer into a Bluescript vector (Stratagene, La Jolla, CA). The cassette encompassing the modified Epo gene preceded by the SV40 promoter was placed, using Clu I linkers, into the Clu I site of the ZenNeo vector.
The psi-2 packaging cell line was plated at lo6 cells in IO mL, 1 day before transfection. The vector plasmid DNAs (10 p g ) were transfected into these cells by the calcium phosphate precipitation method. One day after transfection, the psi-2 cells were plated in 96 wells (4 X 24 well plaques, 1 mL/well) in the presence of 400 pg/mL G41 8 (GIBCO/BRL). After 15 days, G4 18-resistant clones (around 200) were isolated and expanded. For the ZenEpo and ZenEpoK vector-transfected psi-2 cells, conditioned media from confluent cultures were assayed for Epo production, and only the 10 best Epo-producer clones were tested for virus production. The relative viral titers of the psi-2 clones were determined by comparing their ability to convert FDC-PI cells into G4IS-resistant FDC-PI cells. Briefly, 2 X 10' FDC-PI cells were cocultivated in a I:1 ratio with irradiated (20 Gy) psi-2 cells from each clone. After 2 days, nonadherent FDC-P1 cells were collected, washed, and plated at 200 cells/dish in conventional agar cultures in the presence or the absence of G41 8 (1.5 and 2 mg/mL). The percentage of G4 I 8-resistant cells was calculated after 1 week of culture.
UT-7 cell infection procedure. Supernatants from the best virusproducer psi-2 clones were used to infect the amphotropic retroviruspackaging psi-CRIP cell line to produce viruses able to infect the human UT-7 cells. Fresh filtered supernatants (0.22 pm, 2 mL) from confluent psi-2 cultures were used to infect 10' amphotropic psi-CRIP cells in the presence of polybrene (4 pg/mL) for 3 hours. After infection, psi-CRIP cells were cultured for 2 days without G418 to allow Neo resistance gene expression and were then cultured for 1 to 2 weeks in the presence of G41 8 (1 mglmL) to select the infected cells.
Fresh filtered supernatants (0.22 pm, 2 mL) from confluent bulk G418-resistant psi-CRIP cultures were used to infect 5 X IO' UT-7 cells in the presence of GM-CSF and polybrene (4 &nL) for 3 hours. Aliquots of these filtered supernatants were tested for virus titers and the presence of replication-competent virus. After infection, UT-7 cells were washed and cultured without G418 in the presence of GM-CSF. After 2 days, one-third of the bulk-infected UT-7 cell culture was plated in 20 methylcellulose semisolid medium culture dishes, in the presence of G4 I8 ( I mglmL) and GM-CSF,
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Epo assays. Epo concentrations were measured using both a radioimmunologic assay (RIA; Epo-TRAC kit; Sorin Biomedica, Saluggia, Italy) and a biologic assay.
Biologic assays were performed using the microwell assay3' with the UT-7 cell line or the murine DaE7 cell line. Epo concentrations were calculated from rhEpo standards. Because these cell lines respond to several growth fa~tors?*.~~.~' the presence of Epo was ascertained by inhibiting biologically active samples with an Epo antiserum (1,OOO times diluted, a dilution inhibiting 1 U/mL of Epo). RIA was standardized from biologically active monkey Epo.
Cell lysates were prepared from each virus-infected UT-7 clone and parental cells. Cells were washed twice with IMDM and brought to a final cell concentration of 20 X lo6 cells/mL in the lysis buffer (20 mmoVL Tris [pH 8.01 solution containing 10% FCS, 1 mmoVL EDTA, 2 mmoVL phenylmethylsulfonyl fluoride, 1 % aprotinine, and 0.5 m o V L leupeptine). Cells were lysed with 10 cycles of freezing and thawing and were centrifuged at 12,000g for 30 minutes at 4"C, and cell lysates were collected from the supernatants. Epo standards for the calculation of Epo concentrations in cell lysates were parental UT-7 cell lysates in which known amounts of Epo were added to the lysis buffer.
Cell conditioned media were prepared from 2 X 10' cells/mL cultured in IMDM, 10% FCS, in the presence of GM-CSF and collected 2 to 4 days later when the cell concentrations were around 5 to 8 X 10' cells/mL.
The number of Epo molecules was evaluated assuming that 1 mU represented 2.6 X 10' molecules. This calculation is based on a
I I ZEN EPOK
specific activity of 129,000 U/mg of protein and a molecular weight of 18 kD for Epo." RNA analysis. Total cellular RNA was isolated according to the method of Chomczynsky and S a c~h i~~ or Cough3' from infected clones or the UT-7 parental cell line. Northern blot analysis (20 pg of RNA per lane) was performed as previously described,I3 using formaldehyde/agarose gel electrophoresis and transfer to Hybond CExtra membranes (Amersham). cDNA hybridization probes were, for the Epo probe, a 600-bp BamHI-BamHI Epo cDNA fragment from the ZenEpo plasmid DNA; for the Neo probe, a 1,350-bp HindIII-EcoRI Neo cDNA fragment from the ZenNeo plasmid DNA; and for the EpoR probe, an approximately 1,000-bp BgflI-EcoRI fragment from an hEpoR cDNA plasmid.36 RNA integrity was checked by visualizing 28s and 18s ribosomal RNA stained in ethidium bromide.
The polymerase chain reaction (PCR) technique was applied to Epo mRNA as previously de~cribed,'~ with an antisense 3' PCR primer CTTCCAGGCATAGAAATTAAC (nucleotide [nt] 237 to nt 217) and a sense 5' primer GCCCCACCACGCCTCATCTGT (nt 82 to nt 102).
DNA blot hybridization. DNA from UT-7-infected cells was isolated by overnight digestion with proteinase K (0.3 mg/mL) in a 50 mmoVL Tris (pH 8) solution containing sodium dodecyl sulfate (SDS; 0.6%), EDTA (1 mmoVL), and NaCl (100 mmol/L). DNA (IO pg/sample) from ZenEpo and ZenNeo or ZenEpoK virus-infected cells were digested with restriction enzymes EcoRI or Hind111 (GIBCO/BRL), respectively. Digests were size-fractionated in 1% agarose gels and transferred to Hybond C-Extra membranes. The blots were hybridized with the previously described 3zP-labeled Epo cDNA or Neo cDNA probes. Blots were washed 4 times in 2x saline sodium citrate (SSC)/O.l% SDS at room temperature and 3 times in 0.1 X SSC/O.l% SDS at 56°C. Autoradiography was performed using Kodak X-OMAT AR film (Kodak Path& Marne La VallCe, France). pg/mL leupeptine, 10 pg/mL aprotinine, and 2 pg/mL pepstatine. Insolubilized material was removed by centrifugation at 20,OOOg at 4°C for 20 minutes. Supernatants were precleared by incubation for l hour at 4°C with a nonrelevant rabbit antiserum coupled to protein A beads (Pharmacia) and incubated overnight with either Epo or EpoR antisera." Protein A sepharose beads were added, and immunoprecipitates were solubilized by boiling in SDS lysis buffer containing 1 mmol/L orthovanadate and 5% P-mercaptoethanol as previously described." Samples were subjected to SDS-polyacrylamide gel electrophoresis and were electrotransferred onto nitrocellulose filters, and phosphorylated EpoR was detected by immunoblotting with a monoclonal anti-phosphotyrosine antibody (4G10; 2,5 pg/mL; Upstate Biotechnology, Inc. Lake Placid, NY). Immune complexes were revealed using antimouse Ig antibodies coupled to horseradish peroxidase and by chemiluminescence assay according to the manufacturer's instructions (Amersham).
RESULTS

Infection and isolation of UT-7 clones.
To analyze the effects of an Epo autocrine stimulation, we introduced and expressed the Epo gene in the Epo-responsive UT-7 cell line. To determine whether this stimulation can occur intracellularly, a modified-Epo protein (EpoKDEL) containing a COOH-terminal KDEL ER-retention sequence that prevents its secretion was also expressed. Based on our initial difficulties in transfecting genes in UT-7 cells using electroporation techniques, we used a retroviral infection procedure. Two retroviruses were constructed (Fig l) , one carrying the Epo gene (ZenEpo) and the second carrying the modified EpoKDEL gene (ZenEpoK). Both of them exhibited a neomycine resistance (Neo) gene to be used for selection. To avoid saturation of the retention system, the EpoK gene was expressed, as previously described', from a weaker promoter (an internal SV40 early promoter) than the viral LTR. As a control of infection and selection, we analyzed UT-7 cells infected with a Zen Neo virus only carrying the Neo gene (Fig 1) .
The selected ZenEpo virus-producing psi-2 clone secreted 20 U of Epo/mL per 2 X lo5 cells for every 2 days and infected 20% of FDC-P1 cells. In contrast, the selected ZenEpoK virus-producing psi-2 clone infected a similar percentage of FDC-P1 cells (30%) but only secreted 0.02 U of Epo/ mL per 2 X 105 cells for every 2 days, indicating that the retention system was quite efficient.
G418-resistant UT-7 clones, obtained from infection with the supernatant of the bulk G418-resistant psi-CRIP cultures, were individually amplified in liquid cultures.
Conditioned media from all the tested (3418-resistant UT-7 cells were negative for replication-competent virus. Based on DNA hybridization analysis (Fig 2) , we chose several sublines that were independently derived, as shown by each one's distinct proviral integration site: 5 clones infected with the ZenNeo virus (N1, N4, N6, N10, N15), 2 clones infected with the ZenEpo virus (El, E5), and 14 clones infected with the ZenEpoKvirus (K2, K3, K4, K5, K10, K1 1, K14, K16, K19, K21, K22, K24, K27, K32).
RNA hybridization analysis (Fig 2) showed transcripts of the expected sizes. Epo mRNA were transcribed from the retroviral LTR via cryptic splicing (approximately 4.0-and 4.5-kb bands). DEL-modified Epo mRNA were transcribed from the internal SV40 promoter (approximately 1.3-kb band) and the retroviral LTR (approximately 4.0-and 4.5-kb bands). In contrast to the ZenEpoK virus-producer psi-2 clone (PK22), UT-7 sublines showed a small percentage of EpoK mRNA transcribed from the internal promoter, indicating that the SV40 promoter was less efficient in UT-7 cells than in psi-2 cells (Fig 2) . No endogenous Epo transcript (expected size, 1.4 kb) was observed in the ZenNeo virusinfected clones when Northern blot analysis (Fig 2) and reverse transriptase-PCR procedure (data not shown) were used. Minor mRNA transcripts with unexpected sizes were also observed as an approximately 1.3-kb transcript hybridizing with the Epo probe in ZenEpo virus-infected lines (Fig   Epo production. Epo production from UT-7 clones was measured in cell lysates using RIA and biologic assay. The thresholds of the RIA or the biologic assay for Epo standards in cell lysates were around 0.05 U/mL or 0.1 to 0.2 U/mL, respectively. The high threshold of the biologic assay was caused by some toxicity of the undiluted cell lysates. As shown in Fig 3, Epo was cells; mean value t SD, 1.0 t 0.8 U of Epo/mL per 20 X 10' cells). Variations in Epo production observed in these clones may be related to the integration site of the retrovirus, because similar Epo concentrations were detected in different isolates with the same integration site (data not shown). Biologically active Epo was detected in all ZenEpoK virusinfected cell lysates, and the values did not significantly differ from the Epo concentrations determined by RIA (data not shown). These results indicate that KDEL-modified Epo had the same biologic activity as unmodified Epo.
Taking the UT-7 mean volume to be 4 X IO3 pm3, intracellular Epo concentration was calculated to range around 71 and 38 U/mL in El and E5 cells, respectively, and between 38 and 1 U/mL (mean value rt: SD, 12 5 9 U/mL) in ZenEpoK virus-infected cells. This result corresponds to 19,000 and 10, OOO Epo molecules per cell in E1 and E5 cells, respectively, and between 10,000 (K4) and 280 (KIO) Epo molecules per cell in ZenEpoK virus-infected cells (mean value ? SD, 3,500 ? 2,400; see Fig 3) . However, these results are likely to be underevaluated because of the incomplete extraction of Epo from the cells. Use of detergents to improve the extraction did not allow an accurate measurement of the Epo level.
The level of Epo secretion was evaluated by measuring the Epo concentration in conditioned media. RIA (Fig 3) and the biologic assay gave similar results with a threshold close to 0.01 U/mL. El and E5 cells secreted around 1.7 and 1 U of Epo/mL per 2 X 10' cells every 2 to 4 days, respectively. In contrast, low amounts of Epo (from 0.02 to 0.04 U/mL per 2 X 1 Os cells every 2 to 4 days) were detected in the conditioned media from only 3 (K4, K5, K24) of 14 ZenEpoK virus-infected clones. In comparison, the K4 and E5 clones had similar intracellular Epo concentrations, but the K4 cells secreted 97% less Epo (0.03 U/mL) than the E5 cells ( 1 U/mL). These results show that the ER-retention system efficiently impaired Epo secretion in Epo-producing UT-7 cells and resulted in intracellular accumulation of Epo.
Growth characterisrics. Parental UT-7 cell growth is strictly dependent on the presence of growth factors such as Epo or GM-CSF. To know whether retroviral Epo production abolished the growth factor requirement of these cells, virusinfected sublines were cultured without addition of growth factors. No more viable cells were observed in the parental, in the ZenNeo virus-infected cells, and in most of the ZenEpoK virus-infected clones in nonstimulated liquid cultures after 2 weeks. The K4 and K24 lines survived longer in these nonstimulated cultures and showed a variable percentage (around 5% of the total cell number) of viable cells after I month of incubation. This percentage sometimes increased with the duration of culture but decreased as soon as the medium was diluted. This survival was not caused by an increased Epo responsiveness, because the amount of Epo resulting in 50% cell survival after 4 days of incubation was similar in the studied ZenNeo (N15) and ZenEpoK (K2. K3, K4) virus-infected clones (3 1 t 6 mU/mL) and did not differ when the parental cells were used (33 t I O mU/mL). Also, GM-CSF responsiveness did not appear to be affected by the infection, because the amount of GM-CSF resulting in 50% cell survival after 4 days of incubation was similar in the studied ZenNeo (NI, N15) and ZenEpoK (K2, K3, K4, K10) virus-infected clones (29 i 10 pglmL) and did not differ when the parental cells were used (32 i 12 pg/mL). In contrast to all the other clones, the two ZenEpo virusinfected clones, E l and E5, survived and proliferated in unstimulated liquid cultures.
To investigate whether this autonomous growth was caused by either an autocrine or a paracrine stimulation, we analyzed the abilities of the N1, N15, E l , E5, K2, K3, K4, and K10 clones to form colonies in semisolid medium at different cell concentrations in the presence of GM-CSF or without addition of growth factor (Fig 4) . In the presence of GM-CSF, the plating efficiency of these clones varied from 10% to 45% according to the experiments. The same variations were observed using the parental UT-7 cells, showing that the infection and the type of virus used did not influence the plating efficiency of these cells. In the absence of growth factor, parental, N1, N15, and K10 lines did not form colonies, whereas the K2 and K3 clones gave rise to rare clusters in some experiments. The only clones that formed reproducible and significant numbers of colonies independent of added growth factor were E l , E5, and K4. The plating efficiency of E l and E5 clones was not enhanced by the addition of GM-CSF. In contrast, the addition of GM-CSF strongly increased the plating efficiency (by around 80%) and the size of the colonies formed by the K4 clones. Plating efficiency of the K2, K3, K4, E l , and E5 sublines in unstimulated cultures was not dependent on the number of plated cells (from 75 to 2,000 cells/mL), strongly suggesting that colony formation was directly dependent on an autocrine stimulation.
To confirm this hypothesis, the parental, E l , E5, K4, and K3 cells were plated at l cell per well in the presence or the absence of GM-CSF. The cloning efficiency of these cultures was always low (around 6% for the parental cells in the presence of GM-CSF), indicating some difficulty in growing this cell line at the unicellular level. Nevertheless, spontaneous growth of isolated cells was observed for the E l , E5, and K4 cells but not for the parental or the K3 cells. For the K4 cells, l of 66 isolated cells formed a colony in unstimulated cultures. A larger number of colonies (7 of 69 isolated cells) was obtained in the presence of GM-CSF. These results show that a genuine autocrine stimulation, probably dependent on Epo secretion, was responsible for the autonomous growth and/or survival of the Epo-producing cells.
Effects of Epo neutralizing antibodies. To find out if autocrine stimulation requires secretion, we tested the capacities of anti-Epo antibodies to block this autonomous growth (Fig 5) . In all the experiments, the addition of anti-Epo antibodies to unstimulated liquid cultures inhibited both autonomous growth and cell survival of the ZenEpo (El, E5) and ZenEpoK (K4, K l l , K19, K24) virus-infected cells. Such an inhibition was not found in GM-CSF-stimulated cultures, indicating that cell death was not caused by the toxicity of For personal use only. on April 13, 2017 . by guest www.bloodjournal.org From the antibodies. The percentage of inhibition was related to the Epo antiserum concentration, and very high concentrations, inhibiting much more than the amount of Epo released in the cell-conditioned media, were required to obtain significant effects on cell survival. For example, an antibody dilution inhibiting approximately 100 U/mL of Epo was necessary to completely block the proliferation and the survival of the El cells that secreted only 1 to 2 U of Epo per 2 X lo5 cells every 2 to 4 days. These results strongly suggest that the autocrine stimulation induced by Epo in UT-7 cells occurs on the cell surface.
Phenotypes. UT-7 is a pluripotent cell line that undergoes different programs of differentiation depending on the growth factor to which it is exposed. expression of GPA and hemoglobin (Hb). GM-CSF blocks this Epo-dependent erythroid maturation process. To show whether Epo production influences the differentiation capacities of these cells, we analyzed the expression of erythroid (GPA, Hb), megakaryocytic (CD61), and myeloid (CD33) markers in different infected clones stimulated by GM-CSF and/or Epo. In all analyzed clones, results (Fig 6A and B) showed that GM-CSF blocked the GPA and Hb expression induced by Epo. A large variation in the phenotypes of these clones was observed (Fig 6A) , as was the case for clones obtained from the parental cell lines (data not shown). However, no correlation was found, either between Epo production and phenotypes or between Epo production and levels of GPA downregulation by GM-CSF. In addition, the levels of GPA or Hb in the El and E5 cells were similar and were lowered by GM-CSF in both unstimulated (data not shown) and Epo-stimulated cultures. These data indicate that GM-CSF downregulates the erythroid differentiation induced in UT-7 cells either by Epo autocrine stimulation or by exogenously added Epo. Therefore, retroviral Epo production had no differentiative activities when retained in the ER and did not modify the differentiative capacities of this cell line.
EpoR features. We next examined whether Epo production influences EpoR expression and activation. The UT-7 cell line shows around 7,000 EpoR per cell, which are downmodulated by GM-CSF and Epo at the mRNA Binding data showed a reduction in the number of '*'I-Epo binding sites for all analyzed clones in comparison with the parental UT-7 cells (Fig 7A) . ZenNeo and ZenEpoK virusinfected clones showed a similar reduction in the number of binding sites, the mean values ? SD being 55% t 17% and 50% ? 1 1 %, respectively. In contrast, ZenEpo virus-infected clones expressed a more drastic reduction in Epo binding sites than the other clones (mean value 5 SD, 19% 2 7%). This reduction was similar to the one (78%) observed with the parental UT-7 cell line stimulated overnight by Epo. This cannot be explained by EpoR occupancy, because a 2-hour incubation of the parental cells with Epo only slightly reduced the number of binding sites (8%; data not shown), as was found in previous studies with normal cells.38 RNA hybridization analysis (Fig 7B) showed low levels of the EpoR mRNA in the Epo-stimulated or GM-CSF-stimulated parental UT-7 cells and in the two starved ZenEpo virusinfected clones, compared with the levels found in starved ZenEpoK virus-infected clones and controls. These results show that Epo autocrine stimulation downmodulates the EpoR, at the mRNA level, similarly to the way the addition of Epo does in the parental line.33 This process was not observed in KDEL-modified Epo-producing clones which EpoR phosphorylation had occured in these KDEL-modified Epo-producing cells. In contrast, this phosphorylation signal could not be detected after Epo stimulation in the E5 cells, indicating that the EpoR was already stimulated by the continuously secreted Epo. These data strongly suggest that Epo autocrine stimulation induces the phosphorylation of the EpoR through an extracellular stimulation.
DISCUSSION
This report describes an in vitro model of Epo autocrine stimulation. We have used the pluripotent human UT-7 cell line whose growth, differentiation, and survival are strictly dependent on the addition of growth factors including Epo and GM-CSF.z6. 33 We show that retroviral transfer of the Epo cDNA abolished the growth factor requirement of these cells. Spontaneous growth was not cell density-dependent and occurred at unicellular level, thus showing a genuine autocrine mode of stimulation. This autocrine stimulation seemed to be mediated through Epo secretion, because the addition of Epo-neutralizing antibodies inhibited the autonomous growth. In an attempt to confirm this result, Epo secretion was blocked using the KDEL retention signal.39 This approach allowed an intracellular Epo accumulation with little or no Epo secretion. Our data show that a complete Epo secretion blockage resulted in the absence of autonomous growth, whereas a leaky retention system resulted more in a cell survival than in a true long-term proliferation. Furthermore, in contrast to Epo expression, KDEL-modified Epo expression did not induce EpoR downregulation or phosphorylation. All these data strongly suggest that localization of Epo in the ER cannot induce an autocrine stimulation in the UT-7 cell line. Such stimulation is dependent on Epo secretion and appears to take place entirely on the cell membrane.
The C-terminal tetrapeptide KDEL signal is recognized by a membrane-bound receptor, which is responsible for the retrieval of ER proteins from the Golgi apparat~s. 14 independent clones. A leaky retention system, which was probably because of the saturation of this receptor-mediated process, was observed in only 3 clones. A total retention of Epo inside the cell led to the failure of autonomous growth. This failure was not caused by modifications of Epo biologic activity, because immunoreactive KDEL-modified Epo, present in cell lysates or conditioned medium, had the same biologic activity as unmodified Epo, thus demonstrating that the KDEL modification did not modify the affinity of Epo for its receptor. Another explanation could be that intracellular Epo concentration in these clones, probably reduced through the use of an internal promoter: was too low to induce an autocrine stimulation. However, intracellular Epo concentrations in Epo KDEL clones were estimated to be at least from 5 to 200 times more elevated than those required to stimulate the parental cell line (approximately 200 mu/ mL of Epo). Morever, two sublines E5 and K4, obtained with the Zen Epo and Zen Epo KDEL virus, respectively, showed identical intracellular Epo concentrations but showed distinct growth behaviors in nonstimulated cultures. The E5 subline, which secreted large amounts of Epo, showed a complete autonomous growth, whereas the K4 subline, which secreted low amounts of Epo, only survived longer than the parental cells and showed a minimal proliferation or cell survival in nonstimulated cultures. Interestingly, the Epo concentrations released by the clones with a leaky retention system (approximately 30 mU/mL) were close to those inducing a similar partial inhibition of apoptosis in the parental cell line, ie, approximately 50% survival. In contrast, regardless of their intracellular Epo concentration, the Epo KDEL clones showing a total Epo retention in the ER did not survive or proliferate for long periods in the absence of exogenous growth factor. All these results strongly suggest that the growth and survival of the Epo KDELclonei, as well as the Epo clones, were strictly dependent on Epo concentrations released by the cells in the medium. In conformity with these results, when secreted Epo was neutralized by Epo antiserum in Epo or Epo KDEL clone cultures, autonomous survival or proliferation were almost totally inhibited, depending on antibody concentration. The incomplete effect of this antibody inhibition may have resulted either from similar binding affinities for Epo of the antibodies and the receptor or from antibody consumption in the vicinity of the membrane where Epo and EpoR are continuously produced.
Because cell survival and proliferation are only two of the three processes mediated by Epo, we investigated whether intracellular Epo stimulation could eventually mediate an erythroid differentiation. As was recently shown for the G-CSF receptorF4" the differentiative signal pathway induced by the EpoR may be different from the proliferative one. Indeed, it has been reported that herbimycine treatment inhibits the proliferative activity of Epo without affecting its differentiative properties.'" In contrast, myeloid cells transfected with the EpoR gene proliferate but fail to differentiate in response to Ep0.4'' Recently, it has also been suggested that intracellular stimulation by Epo of murine stem cells may induce erythroid commitment without proliferati0n.4~ However, despite the large number of isolated clones, we were unable to find any differences in the phenotype of the Epo-producing clones in comparison with the control Neo clones in GM-CSF-stimulated cultures. As in the parental cell line and the control Neo clones, exogenous Epo induced an erythroid differentiation process that was blocked For personal use only. on April 13, 2017 . by guest www.bloodjournal.org From by the addition of GM-CSF. The only difference was observed in Epo-secreting clones where the addition of exogenous Epo did not modify the phenotype. However, the addition of GM-CSF still reverted the erythroid phenotype of these clones. Thus, Epo production did not change the differentiation capacities of this cell line and had no erythoid differentiation activity when Epo was retained in the ER.
From all these data, it appears that intracellular Epo was not effective in the induction of cell survival, proliferation, or differentiation. We wonder whether this was because of an inability of Epo to stimulate its receptor inside the cell. In many models, intracellular autocrine stimulation modifies receptor metabolism, inducing its downregulation and eventually its activation. However, this intracellular activation of the receptor is not always sufficient and may also require expression on the cell surface for complete transformation or cell pr~liferation.~' EpoR belongs to the superfamily of cytokine receptors. Tyrosine phosphorylations are essential for its signal transduction, although these receptors have no intrinsic kinase activity. Several studies have recently shown that these receptors are closely associated with cytoplasmic kinases." In the parental cell line, we showed that stimulation by Epo induces a downregulation of the EpoR (binding and mRNA) and the phosphorylation of several proteins including the EpoR."." To study the metabolism of EpoR induced by an Epo autocrine stimulation, we compared Epo binding sites and EpoR phosphorylation of the ZenNeo. ZenEpo, and ZenEpoK virus-infected clones. KDEL Epo and Neo expressing cells showed a similar number of surface EpoR. Surprisingly, all these clones showed a lower number of EpoR than the parental cell line. The most likely explanations were that either retroviral infection or selection procedures are responsible for this lower level of surface EpoR. Nevertheless, the Epo clones showed a further twofold reduction in their Epo-binding capacities compared with those of the control ZenNeo virus-infected clones. A similar reduction was also observed at the EpoR mRNA levels. Thus, in contrast to Epo, the KDEL-modified Epo production did not induce any downregulation of the EpoR. Phosphorylation of the EpoR in response to exogenous Epo was shown in the Neo control clone as well as in the clones expressing KDELEpo but not in the one expressing Epo. These data indicate that the EpoR is constitutively activated in the Epo clones but not in the KDEL-Epo clones. Two main hypotheses could explain the absence of EpoR activation in the Epo KDEL clones. First, to be active, EpoR must be coupled to a kinase, and recent evidence suggests that this kinase is JAK2.52 If this association does not take place in the ER, the binding of Epo to its receptor in the ER will be unable to transduce a message. Second, no Epo-EpoR complexes can be formed in the ER. The absence of EpoR downregulation in Epo KDEL clones, which is observed for some other receptors when coexpressed with their KDEL-modified ligand~:',~~ provides strong evidence in favor of this second hypothesis. One can argue that the KDEL modification has impaired the Epo-EpoR interaction, but this is rather unlikely, because EpoKDEL has the same biologic activity as Epo. Furthermore, our preliminary experiments have failed to detect any intracellular immunocomplexes not only between EpoR and Epo KDEL, but also between EpoR and unmodified Epo. The most likely explanations for the absence of intracellular Epo-EpoR complexes might be (1) that both molecules traffic in two different ER compartments or ( 2 ) that the structure of the EpoR in the ER does not allow Epo binding. In the Friend model, intracellular interaction of EpoR and gp55 actually occurs in the ER inducing intracellular gp55-EpoR complexes and EpoR d o~n r e g u l a t i o n .~~ This difference may be explained by the fact that Epo and gp55 have different binding sites on the E~o R . '~ However, elegant data show that EpoWgp55 complexes are also detectable at the cell surface53 and that growth stimulation is indeed related to this low number of EpoWgp55 complexes present on the cell surfa~e.'~*~' Therefore, even in this model, only the external activation seems crucial.
The KDEL retention signal has previously been used with other factors to locate the cellular sites of autocrine mechanisms, and different results have been obtained, depending on the growth factor studied. Intracellular retention of IL-3' or the v-sis product6 did not impair their proliferative activities. In contrast, the autocrine activity of K-FGF was impaired after addition of the KDEL signal.' These differences may be related to different mitogenic pathways or receptorligand binding requirements but do not seem to be dependent on their receptor family. K-FGF and v-sis receptors both have intrinsic tyrosine kinase activity, and the IL-3 receptor belongs to the same receptor family as the EpoR. An alternative explanation is that, in many previous studies, the existence of a leaky retention system has not been extensively examined. Recent experiments using the v-si.~'" or IL-3" genes engineered for intracellular retention suggest that induction of proliferation was also related to secretion.
In conclusion, Epo autocrine stimulation in UT-7 cells was shown to be strictly dependent on Epo secretion and resulted in biologic effects similar to exogenously added Epo. These results strongly suggest that autocrine stimulation differs from endocrine or paracrine stimulation only by the absence of physiologically regulated growth factor production.
